Rosa Rehab,l.l.c. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4037 Branch Ave, Temple Hills, MD 20748 Phone: 301-316-2111 Fax: 301-316-5382 |
Dr. Ngoc Tran Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 3731 Branch Ave, B312, Temple Hills, MD 20748 Phone: 301-899-0915 |
Dr. Schmekia Monique Jackson, D.C Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4302 Saint Barnabas Rd, Suite A, Temple Hills, MD 20748 Phone: 240-788-6412 Fax: 240-788-6435 |
Dr. Rick Rosa, D.C. Chiropractor - Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4269 Branch Ave, Temple Hills, MD 20748 Phone: 301-316-2111 Fax: 301-316-5382 |
Rosavan Temple Hills Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4037 Branch Ave, Temple Hills, MD 20748 Phone: 240-863-2822 |
Jasemon Franklin Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4302 Saint Barnabas Rd, Suite A, Temple Hills, MD 20748 Phone: 240-788-6412 |
News Archive
People could soon be using their smartphones to combat a deadly form of air pollution, thanks to a potentially life-saving breakthrough by RMIT University researchers in Melbourne, Australia.
Better access to on-demand transportation could help older adults miss fewer medical appointments as well as reduce their social isolation to improve their overall health, suggests a new study published in the Journal of mHealth by researchers at the USC Center for Body Computing at the Keck School of Medicine of USC.
A group of former U.S. military leaders have joined "recent calls by Defense Secretary Robert Gates and Chairman of the Joint Chiefs of Staff Adm. Michael Mullen to expand U.S. civilian capacities to reduce dependence on the military," Politico's Laura Rozen reports on her blog.
Within the "umbrella" of rare diseases, rare cancer patients confront particular problems. Most rare diseases have an identified genetic origin. In contrast, rare cancers are mainly acquired diseases.
A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial, to be presented at the American Heart Association Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function). However, spironolactone did reduce the major burden faced by these patients-the risk of repeated hospitalizations for heart failure.
› Verified 5 days ago